Opus Genetics, Inc.

NasdaqCM:IRD Stock Report

Market Cap: US$302.0m

Opus Genetics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:IRD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 May 26SellUS$7,395,000Foundation Fighting BlindnessCompany1,700,000US$4.35
23 Apr 26SellUS$40,658Robert GagnonIndividual7,842US$5.18
23 Apr 26SellUS$39,156Ashwath JayagopalIndividual7,542US$5.19
23 Apr 26SellUS$8,540Amy Zaremba RabournIndividual1,641US$5.20
23 Apr 26SellUS$39,121Benjamin YerxaIndividual7,470US$5.24
23 Apr 26SellUS$49,647George MagrathIndividual9,511US$5.22
23 Apr 26SellUS$24,519Joseph SchachleIndividual4,697US$5.22
16 Mar 26SellUS$127,327George MagrathIndividual24,438US$5.21
16 Mar 26SellUS$14,770Amy Zaremba RabournIndividual2,816US$5.25
16 Mar 26SellUS$19,525Joseph SchachleIndividual3,719US$5.25
16 Mar 26SellUS$19,046Ashwath JayagopalIndividual3,719US$5.12
29 Dec 25BuyUS$323,693Cameron GallagherIndividual164,000US$1.98
09 Dec 25SellUS$8,600,000Foundation Fighting BlindnessCompany4,000,000US$2.15

Insider Trading Volume

Insider Buying: IRD insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of IRD?
Owner TypeNumber of SharesOwnership Percentage
Private Companies28,5640.0351%
Individual Insiders5,864,7177.21%
Hedge Funds12,104,80314.9%
General Public26,268,64832.3%
Institutions37,128,80745.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 36.4%.

Top Shareholders

Top 25 shareholders own 60.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.46%
Caligan Partners, LP
6,075,028US$22.5m0%no data
7.41%
Adage Capital Management, L.P.
6,029,775US$22.4m446%no data
4.66%
Foundation Fighting Blindness
3,792,171US$14.1m-31%no data
4.53%
Bios Equity Partners LP
3,683,429US$13.7m0%no data
3.34%
Balyasny Asset Management L.P.
2,718,029US$10.1m0%no data
3.23%
Millennium Management LLC
2,630,432US$9.8m31.4%no data
3.01%
Vanguard Capital Management, LLC
2,449,987US$9.1m0%no data
2.84%
Marshall Wace LLP
2,313,380US$8.6m1,370%no data
2.76%
Boxer Capital Management, LLC
2,250,000US$8.3m0%no data
2.43%
Cameron Gallagher
1,974,430US$7.3m4.2%no data
2.27%
ADAR1 Capital Management, LLC
1,849,004US$6.9m4,520%no data
2.26%
Perceptive Advisors LLC
1,835,842US$6.8m-57.6%no data
2.07%
Nantahala Capital Management, LLC
1,681,330US$6.2m-64.8%no data
1.66%
Woodline Partners LP
1,354,030US$5.0m0%no data
1.46%
Boothbay Fund Management, LLC
1,189,113US$4.4m0%no data
1.38%
Opaleye Management Inc.
1,120,000US$4.2m0%no data
1.23%
Farallon Capital Management, L.L.C.
1,000,000US$3.7m0%no data
1.03%
George Magrath
839,910US$3.1m2.53%no data
1.01%
Susquehanna International Group, LLP
823,383US$3.1m308%no data
0.91%
Bleichroeder LP
736,842US$2.7m0%no data
0.87%
Benjamin Yerxa
711,535US$2.6m925%no data
0.73%
Robert Gagnon
592,158US$2.2m0%no data
0.73%
Mink Brook Asset Management LLC
590,552US$2.2m-64.5%no data
0.66%
Geode Capital Management, LLC
538,347US$2.0m6.61%no data
0.61%
Trails Edge Capital Partners, LP
500,000US$1.9m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/25 01:18
End of Day Share Price 2026/06/25 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Opus Genetics, Inc. is covered by 18 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Madison Wynne El-SaadiB. Riley Securities, Inc.
Kumaraguru RajaBrookline Capital Markets